ILK and cancer: Furthermore, ILK was significantly correlated with B cells and CD8+ T cells in 10 cancers, with CD4+ T cells in 24 cancers, with macrophages and neutrophils in 23 cancers, and with DCs in 28 cancers (Supplementary Figure 2).